About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Colorectal Cancer Clinical Trials in Houston | 462 Studies

Clinical Trials Colorectal CancerHouston

Colorectal Cancer Clinical Trials in Houston

Find 462 clinical trials for colorectal cancer near Houston, Texas. Connect with research centers in your area.

All Colorectal Cancer trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 41-60 of 462 trials

Active not recruitingMicrowave Ablation or Wedge Resection for the Treatment of Lung, Sarcoma and Colorectal Lesions, ALLUME StudyThis study compares the outcomes and safety of two standard treatment options called microwave ablation and surgical wedge resection in patients with non-small cell lung cancer…NCT04430725·Houston, Texas CompletedChromogranin A as Blood Marker in Cancer PatientsGastroentero-pancreatic neuroendocrine tumors (GEP-NETs) are a heterogenous group of neoplasms that arise from enterochromaffin cells of the gastrointestinal (GI) tract and…NCT03817866·Palo Alto, California and 3 others

Colorectal Cancer Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedInterleukin-12 in Treating Patients With Cancer in the AbdomenRATIONALE: Interleukin-12 may kill tumor cells by stimulating a person's white blood cells to kill cancer cells.NCT00003046·Houston, Texas

CompletedRadiofrequency Ablation Followed By Hepatic Artery Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the LiverRATIONALE: Radiofrequency ablation may be able to shrink or destroy cancer cells.NCT00004142·Houston, Texas

CompletedThe National CT Colonography TrialRATIONALE: New diagnostic procedures such as computed tomographic colonography may improve the ability to detect colorectal cancer and may provide a less invasive method of…NCT00084929·Scottsdale, Arizona and 13 others

TerminatedREVEAL Study of NKTR-262 in Combination With NKTR-214 and Nivolumab in Patients With Locally Advanced / Metastatic Solid Tumor MalignanciesPatients received intratumoral (IT) injections of NKTR-262 in 3-week cycles for up to 3 cycles; bempegaldesleukin with or without nivolumab was administered every 3 weeks (q3w)…NCT03435640·Scottsdale, Arizona and 13 others

Active not recruitingA Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid TumorsThe main purpose of the study is to assess whether the study drug, LY4066434, is safe and tolerable when administered to participants with locally advanced or metastatic solid…NCT06607185·Birmingham, Alabama and 44 others

CompletedDS-8201a in Human Epidermal Growth Factor Receptor2 (HER2)-Expressing Colorectal Cancer (DESTINY-CRC01)The main objective of this study is to test the safety and effectiveness of DS-8201a for participants with HER2-expressing advanced colorectal cancer.NCT03384940·Duarte, California and 24 others

TerminatedRosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By SurgeryRATIONALE: Rosuvastatin may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.NCT01011478·Anniston, Alabama and 586 others

RecruitingMOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid TumorsThe main purpose of this study is to assess safety \& tolerability and antitumor activity of LY3962673 as monotherapy and in combination with other chemotherapy agents in…NCT06586515·Duarte, California and 51 others

Active not recruitingEvaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ TumorsThis study will evaluate safety, pharmacodynamics and biomarkers of subcutaneous (SC) DK210(EGFR) given as monotherapy and in combination with immunotherapy, chemotherapy or…NCT05704985·Duarte, California and 6 others

CompletedQuality Improvement of Patient-Provider Communication For Colorectal Cancer ScreeningThe immediate objective of this proposal is to assess the effectiveness of a multi-faceted intervention to improve patient-provider communication about colorectal cancer screening…NCT00324753·Chicago, Illinois and 2 others

RecruitingFT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid TumorsThis is a Phase 1 study of FT836 administered in participants with advanced solid tumors.NCT07216105·La Jolla, California and 4 others

Active not recruitingYoung-Onset Colorectal CancerThis study investigates the genetic factors that may influence the risk of developing colorectal cancer at a young age.NCT02863107·Conroe, Texas and 4 others

Active not recruitingA Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.The purpose of this study is to learn about the safety and effects of the study medicine alone or when given together with other anti-cancer therapies.NCT06447662·Fayetteville, Arkansas and 26 others

Active not recruitingCancer Preventive Vaccine Nous-209 for Lynch Syndrome PatientsThis phase Ib/II trial evaluates the safety and effect of the Nous-209 vaccine in Lynch syndrome patients.NCT05078866·Duarte, California and 3 others

Active not recruitingChemotherapy and/or Metastasectomy in Treating Patients With Metastatic Colorectal Adenocarcinoma With Lung MetastasesThis phase II trial studies how well chemotherapy and/or metastasectomy work in treating patients with colorectal adenocarcinoma that has spread to the lungs (metastases).NCT03599752·St Louis, Missouri and 5 others

CompletedA Study of PDR001 in Combination With CJM112, EGF816, Ilaris® (Canakinumab) or Mekinist® (Trametinib)The purpose of this study was to combine the PDR001 checkpoint inhibitor with each of four agents with immunomodulatory activity to identify the doses and schedule for combination…NCT02900664·Baltimore, Maryland and 22 others

Active not recruitingTesting the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH TrialThe dose escalation phase of this trial identifies the safety, side effects and best dose of ceralasertib (AZD6738) when given in combination with trastuzumab deruxtecan…NCT04704661·Irvine, California and 22 others

RecruitingSYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryInternational registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical trial matching tool…NCT03452774·Birmingham, Alabama and 67 others

PreviousPage 3 of 24Next

Other Conditions in Houston

Breast Cancer Lung Cancer Prostate Cancer Melanoma Leukemia Lymphoma